Jin Song

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

X. Yi, Yuquan Wei, T. Deng, 2020, Nature Medicine.

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

X. Yi, H. Lyerly, M. Morse, 2018, Clinical Cancer Research.

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

X. Yi, Yuquan Wei, T. Deng, 2020, Nature Medicine.

AutologousDendritic Cell-Cytokine InducedKiller Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer : A Prospective Study

X. Yi, H. Lyerly, M. Morse, 2019 .

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study

X. Yi, Yanjie Zhao, H. Lyerly, 2017, Clinical Cancer Research.

Two case reports of non-small cell lung cancer patients harboring acquired EGFR T790M-cis-C797S benefit from immune checkpoint inhibitor combined with platinum-based doublet chemotherapy

Youchao Jia, A. Zang, Zi-Zheng Song, 2022, Annals of translational medicine.